$99M
Qualified
maximum offering price, as qualified
$60M
Reported Sold
1-K 2022-04-29
22
Filings
across 3 offerings
Equity Classes
| Type | Class | Outstanding |
|---|---|---|
| common | Common Stock | 22,073,976 |
Service Providers
| Role | Provider |
|---|---|
| auditor | Deloitte & Touche LLP |
| blue sky | Various states |
| legal | Greenberg Traurig, P.A. |
| sales commission | Dalmore Group, LLC |
Offerings
| File Number | Filings | First Filed | Last Filed | Qualified | Commenced | Price/Security | Securities Offered | Securities Sold | Qualified Sold | Outstanding | Aggregate Offering | Proceeds Reported | Issuer Portion | Selling Holders | Prior 12mo Qualified | Concurrent Offering | Estimated Net | Supplements | Last Supplement | Withdrawn | CRD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 024-10810 | 15 | 2018-03-05 | 2022-04-29 | 2020-11-24 | 2019-03-03 | $6.00 | 2,850,000 | 10,422,776 | 12,850,000 | 19,054,632 | $49M | $60M | $17.1M | $0 | $31.9M | $0 | $56.2M | 11 | 2020-12-02 | 2019-05-20 | 136352 |
| 024-11591 | 2 | 2021-07-26 | 2021-10-06 | — | — | $8.00 | 6,250,000 | — | — | 22,065,147 | $50M | — | — | — | — | — | $48.5M | — | — | — | 136352 |
Current Reports
| Filing Date | Form | Event | Items |
|---|---|---|---|
| 2024-03-19 | 1-U | Departure of Officers | 7 |
| 2023-04-28 | 1-U | Other Events | 9.1 |
| 2023-03-24 | 1-U | Other Events | 9.1 |
| 2022-10-28 | 1-U | Departure of Officers | 7 |
| 2022-08-19 | 1-U | Other Events | 9.1 |
| 2022-07-28 | 1-U | Other Events | 9.1 |
| 2022-07-08 | 1-U | Departure of Officers | 7,9.1 |
| 2021-04-06 | 1-U | Other Events | 9.1 |
| 2021-03-09 | 1-U | Other Events | 9.1 |
| 2021-02-16 | 1-U | Other Events | 9.1 |
| 2020-12-30 | 1-U | Other Events | 9.1 |
| 2020-10-20 | 1-U | Other Events | 9.1 |
| 2019-12-09 | 1-U | Other Events | 9.1 |
| 2019-11-21 | 1-U | Other Events | 9.1 |
| 2019-06-12 | 1-U | Unregistered Sales of Equity | 8 |
| 2019-05-30 | 1-U | Other Events | 9.1 |
| 2019-03-11 | 1-U | Other Events | 9.1 |
| 2018-12-28 | 1-U | Unregistered Sales of Equity | 8 |
| 2018-07-06 | 1-U | Departure of Officers | 7 |
The statements and reported figures behind Emerald Health Pharmaceuticals Inc.
Operations, the balance sheet and cash flows as filed, year by year — the filer's own captions, not a mapped chart of accounts — plus the tagged figures from every Form 1-A family filing, plotted on the dates they were actually reported. EDGAR still has each 1-K; the dashboard lays every year they filed next to it.
- Every caption as the filer wrote it, across every annual report — not just the latest 1-K
- Tagged reported figures across every filing — revenue, assets, cash — with a sparkline on the actual filing dates
- A sparkline on each annual-statement line, so the shape is visible before the figures
- A revenue series dated to the filings that reported it
- A filing history that says what each document contributed, not only that it exists
- Follow it, and see it change on your watchlist
External link: SEC Filings